Buruli kalinyaɣu

Buruli kalinyaɣu
class of disease
Yaɣ sheliprimary bacterial infectious disease, mycobacterium infectious disease, neglected tropical disease, Dɔriti Mali niŋ
N tahiinfection Mali niŋ
Health specialtyinfectious diseases Mali niŋ
Symptoms and signsnecrosis Mali niŋ
NCI Thesaurus IDC84604 Mali niŋ
E-Class

Buruli kalinyaɣu (Buruli ulcer, Bairnsdale ulcer, Searls ulcer, bei (Daintree ulcer) [1][2][3]) nyԑla dɔri loorili shԑli ‘’Mycobacterium ulcerans’’ ni tahiri na.[4] Doro ŋɔ piligu nahiŋgbaŋ kpani n nyԑ niŋgbiŋ zuɣu din ka biԑrim.[4] chebli ŋɔ ni tooi lԑbi kalinyaɣu.[4] kalinyaɣu ŋɔ ni tooi galisi niŋgbiŋ puuni n gari dini wuhi dimaŋ shԑm sambani ni,[5] ka sahashԑŋa kaliwaya tooi gili li.[5] Doro ŋɔ yi ti tooni, din di n gbaai sal kɔbli.[4] Buruli yuma ŋɔ ni gbaari luɣa shԑŋa pam n nyԑ baɣri ni gbaya; di bi tahiri ningbiŋ biisim na.[4]

Din tahiri buruli kalinyari na

M. ulcerans bahiri la lɔɣu shԑli booni mycolactone, din gbarigiri ninsala ka kuri o Ʒim.[4] M. ulcerans ŋɔ lahingbani ŋmanila binniԑ bihi shԑŋa ba tahi ri kohindotontoŋ mini sinsiŋkoŋ na.[4] Doro ŋɔ ni loori shԑm ti bi mi.[4] Ti zilsilri kɔm bilisibu shԑhi.[5] Din gbaai 2013 yuuni pulni, doro ŋɔ n aka tilaa.[4][6]

Tibbu

Bari yi daŋ nya tibbu, an-tibiotics tim nyubu chira ayi niribu anii pii kam pubzuɣu nyԑri faako.[4] Tilaa ŋɔ galsi sheŋa n nyԑ rifampicin mini streptomycin.[4] Clarithromycin bei moxifloxacin ni tooi zani streptomycin zaani.[4] Saha shaŋa bieni doro ŋo tibbu ni ka alaafei baŋdiba yen ŋmaai Buruli kalinyari ŋo bahi.[4][7] Doro ŋɔ kalinsi nyaanga wulԑɣu bei wuleri ni yi palo.[6]

Taɣibu

Buruli kalinyaɣu doro ŋɔ ni wuli luɣu shԑŋa n nyԑ sub-Saharan Africa balanteei Cote d'Ivoire, amaa di bi ziԑm salinima ban be Asia, Western Pacific ni Americas tingbana ni.[4] Andunia tinsi pihita ni ayi ka doro ŋɔ barinima be.[5] Yuuni kam pulini doro ŋɔ gbaari niriba ban kalinli ni paagi 5000-6000. Doro ŋɔ ni tooi gbaai binkɔbgu gba.[4] Albert Ruskin Cook n nyԑ ninvuɣuso ŋun daŋ vihi doro ŋɔ zuɣu yuuni 1897.[5]

Kundivihira

[mali niŋ | mali mi di yibu sheena n-niŋ]
  1. ↑ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. p. 340. ISBN 0-7216-2921-0. Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  2. ↑ Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. Chapter 74. ISBN 1-4160-2999-0.CS1 maint: multiple names: authors list (link)
  3. ↑ Lavender CJ, Senanayake SN, Fyfe JA, et al. (January 2007). "First case of Mycobacterium ulcerans disease (Bairnsdale or Buruli ulcer) acquired in New South Wales". Med. J. Aust. 186 (2): 62–3. PMID 17223764.
  4. ↑ 4.00 4.01 4.02 4.03 4.04 4.05 4.06 4.07 4.08 4.09 4.10 4.11 4.12 4.13 4.14 Buruli ulcer (Mycobacterium ulcerans infection) Fact sheet N°199. World Health Organization (June 2013). Retrieved 23 February 2014.
  5. ↑ 5.0 5.1 5.2 5.3 5.4 Nakanaga, K (2013). "Buruli ulcer and mycolactone-producing mycobacteria.". Japanese journal of infectious diseases 66 (2): 83–8. PMID 23514902.
  6. ↑ 6.0 6.1 Einarsdottir T, Huygen K (November 2011). "Buruli ulcer". Hum Vaccin 7 (11): 1198–203. DOI:10.4161/hv.7.11.17751. PMID 22048117.
  7. ↑ Sizaire V, Nackers F, Comte E, Portaels F (2006). "Mycobacterium ulcerans infection: control, diagnosis, and treatment". Lancet Infect Dis 6 (5): 288–296. DOI:10.1016/S1473-3099(06)70464-9. PMID 16631549.